Back to Schonfeld Strategic Advisors LLC Schonfeld Strategic Advisors LLC

ESPRESPR
20 quarters

Position history for Schonfeld Strategic Advisors LLCSchonfeld Strategic Advisors LLC's holdings in ESPERION THERAPEUTICS INC NE

Schonfeld Strategic Advisors LLC holds 1.3M shares of ESPR (ESPERION THERAPEUTICS INC NE), worth $4M as of 2026-Q2. This is a new position. ESPR represents 0.0% of Schonfeld Strategic Advisors LLC's portfolio.

Current Value

$4M

Current Shares

1.3M

Total Value Change

-$2.7M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
1.3M
-
$4M0.0%$3.16
37
2026-Q1
Exited
0
-100.0%
$00.0%$2.91
0
2025-Q4
New
75,238
-
$278,3800.0%$3.69
32
2024-Q4
Exited
0
-100.0%
$00.0%$2.15
0
2024-Q3
Decreased
518,100
-38.9%
$854,8650.0%$1.68
0
2024-Q2
Decreased
847,727
-10.5%
$1.9M0.0%$2.22
0
2024-Q1
Decreased
947,506
-13.2%
$2.5M0.0%$2.68
0
2023-Q4
Decreased
1.1M
-11.4%
$3.3M0.0%$2.99
0
2023-Q3
Decreased
1.2M
-6.4%
$1.2M0.0%$0.98
0
2023-Q2
Decreased
1.3M
-27.3%
$1.8M0.0%$1.34
0
2023-Q1
Increased
1.8M
+156.0%
$2.9M0.0%$1.67
42
2022-Q4
Decreased
707,052
-12.0%
$4.4M0.0%$6.23
0
2022-Q3
Increased
803,069
+1238.5%
$5.4M0.0%$6.84
44
2022-Q2
Decreased
60,000
-43.9%
$382,0000.0%$6.67
0
2022-Q1
Decreased
106,900
-63.2%
$496,0000.0%$4.89
0
2021-Q4
Increased
290,300
+2010.2%
$1.5M0.0%$4.96
41
2021-Q3
Decreased
13,757
-77.1%
$166,0000.0%$12.44
0
2021-Q2
New
60,065
-
$1.3M0.0%$21.13
35
2019-Q4
Exited
0
-100.0%
$00.0%$59.82
0
2019-Q3
New
182,019
-
$6.7M0.2%$37.78
45

Other major holders of ESPR: BNP PARIBAS FINANCIAL MARKETS, Pentwater Capital Management LP, WASATCH ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used